Bausch Health Companies | VRX - Trade Debtors

Stock Price
8.00
Daily Change
0.16 2.04%
Monthly
-26.94%
Yearly
-13.33%
Q1 Forecast
7.62

Bausch Health Companies reported $2.42B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Amgen USD 8.49B 211M Sep/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Bausch Health Companies USD 2.42B 207M Sep/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Danaher USD 3.91B 762M Dec/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 5.1B 314M Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Pacira USD 115.27M 901K Sep/2025
Perrigo USD 644.4M 62.2M Sep/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Supernus Pharmaceuticals USD 171.25M 30.42M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025
Zoetis USD 1.54B 1000K Sep/2025